Article info
Clinical science
Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma
- Correspondence to Mandeep S Sagoo, Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, City Road, London EC1V 2PD, UK; mandeep.sagoo1{at}nhs.net
Citation
Outcomes of intravitreal methotrexate to salvage eyes with relapsed primary intraocular lymphoma
Publication history
- Received June 29, 2020
- Revised September 26, 2020
- Accepted September 29, 2020
- First published October 21, 2020.
Online issue publication
May 11, 2023
Article Versions
- Previous version (11 May 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.